| The role of sialidase in the development of hypocomplementemia in postinfectious acute glomerulonephritis. | |
| | |
MedLine Citation:
|
PMID: 10413657 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The role of sialidase in complement activation and in development of hypocomplementemia in patients with postinfectious acute glomerulonephritis (AGN) was investigated. In sera from 17 patients with AGN and 14 healthy controls, sialidase activity and serum levels of free and total sialic acid were measured by previously established methods. Circulating sialidase activity and serum levels of free and total sialic acid and haptoglobin were increased, and the C3 level was decreased in the acute phase of AGN. There was no correlation between free sialic acid and total sialic acid, which increased in parallel with serum levels of haptoglobin, one of the acute-phase reactants. A follow-up study of these parameters in a typical case reflected this tendency and suggested that increased sialidase after infection, in addition to complement activation by the infectious substance, could play a role in development of hypocomplementemia. To clarify this mechanism, purified neuraminidase was incubated with normal human serum under various conditions. Complement breakdown products were measured in the incubation mixture by enzyme-linked immunosorbent assay using monoclonal antibodies against iC3b, Bb, and C4d neoantigens. iC3b was generated dose-dependently in the presence of neuraminidase. Further examination revealed that iC3b and Bb were generated in the incubation mixture with neuraminidase and NHS and that C4d was not detected in the same mixture. These findings indicate that neuraminidase activates the alternative complement pathway. These in vitro data, together with the former in vivo data led us to conclude that increased sialidase after infection could accelerate the complement amplification system, resulting in hypocomplementemia in the acute phase of postinfectious AGN. |
| | |
Authors:
|
T Fujita; H Ohi; M Endo; I Ohsawa; K Kanmatsuse |
Related Documents
:
|
4291317 - Release of carbohydrates from sphingoglycolipid by osmium-catalyzed periodate oxidation... 606237 - The biosynthesis of brain gangliosides. separation of membranes with different ratios o... 3673337 - Oncolysis by clostridium oncolyticum m55 and subsequent enzymatic determination of sial... 9586577 - Importance of sialic acid in recombinant thrombomodulin in terms of pharmacokinetics an... 17342727 - Concentration and composition of free amino acids and osmolalities of porcine oviductal... 18253497 - Mitochondrial lactate dehydrogenase is involved in oxidative-energy metabolism in human... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical immunology (Orlando, Fla.) Volume: 92 ISSN: 1521-6616 ISO Abbreviation: Clin. Immunol. Publication Date: 1999 Jul |
Date Detail:
|
Created Date: 1999-07-30 Completed Date: 1999-07-30 Revised Date: 2005-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 100883537 Medline TA: Clin Immunol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 97-102 Citation Subset: IM |
Copyright Information:
|
Copyright 1999 Academic Press. |
Affiliation:
|
Department of Internal Medicine II, Nihon University School of Medicine, Tokyo, 173-8610, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Complement Activation Complement Pathway, Alternative / drug effects Complement System Proteins / metabolism* Glomerulonephritis / blood*, immunology* Humans N-Acetylneuraminic Acid / blood Neuraminidase / blood, pharmacology, physiology* |
| Chemical | |
Reg. No./Substance:
|
131-48-6/N-Acetylneuraminic Acid; 9007-36-7/Complement System Proteins; EC 3.2.1.18/Neuraminidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.
Next Document: Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-...